(Q39959699)

15 September 2017

title

Ligand binding and antigenic properties of a human neonatal Fc receptor with mutation of two unpaired cysteine residues (English)

1 reference

15 September 2017

1 reference

1

1 reference

15 September 2017

4

1 reference

15 September 2017

10

Inger Sandlie

1 reference

15 September 2017

Sune Justesen

2

1 reference

15 September 2017

Burkhard Fleckenstein

3

1 reference

15 September 2017

Gøril Berntzen

5

1 reference

15 September 2017

Vania E Kenanova

6

1 reference

15 September 2017

Muluneh B Daba

7

1 reference

15 September 2017

Vigdis Lauvrak

8

1 reference

15 September 2017

Søren Buus

9

1 reference

15 September 2017

language of work or name

English

0 references

publication date

15 July 2008

1 reference

15 September 2017

1 reference

15 September 2017

volume

275

1 reference

15 September 2017

issue

16

1 reference

15 September 2017

page(s)

4097-4110

1 reference

Perspective-- FcRn transports albumin: relevance to immunology and medicine

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

FcRn: the neonatal Fc receptor comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Crystal structure of the complex of rat neonatal Fc receptor with Fc

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor(,)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Ontogenetic development and distribution of antibody transport and Fc receptor mRNA expression in rat intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Divergent activities of an engineered antibody in murine and human systems have implications for therapeutic antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Pulmonary delivery of an erythropoietin Fc fusion protein in non-human primates through an immunoglobulin transport pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Oral and pulmonary delivery of FSH-Fc fusion proteins via neonatal Fc receptor-mediated transcytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site-directed mutagenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH-dependent binding to albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Engineered human IgG antibodies with longer serum half-lives in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

An engineered human IgG1 antibody with longer serum half-life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Radioiodinated versus radiometal-labeled anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments: optimal pharmacokinetics for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Albinterferon alpha-2b: a genetic fusion protein for the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Purification of correctly oxidized MHC class I heavy-chain molecules under denaturing conditions: a novel strategy exploiting disulfide assisted protein folding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

A strategy for bacterial production of a soluble functional human neonatal Fc receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Expression and crystallization of a soluble and functional form of an Fc receptor related to class I histocompatibility molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Albumin binding to FcRn: distinct from the FcRn-IgG interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

21 January 2018

Vicinal disulfide turns

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Membrane-anchored human FcRn can oligomerize in the absence of IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Increasing the serum persistence of an IgG fragment by random mutagenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Engineering novel binding proteins from nonimmunoglobulin domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Domain antibodies: proteins for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Nanobodies as novel agents for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

Efficient assembly of recombinant major histocompatibility complex class I molecules with preformed disulfide bonds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2008.06551.X

10.1111/J.1742-4658.2008.06551.X

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference